Pathologic downstaging with taxane-based neoadjuvant chemotherapy correlates with increased survival in patients with locally advanced esophageal cancer

Michael K. Gibson,Malcolm V. Brock,Elizabeth A. Montgomery,Joseph M. Herman,Stephen B. Baylin,Elisabeth I. Heath,Richard F. Heitmiller,Arlene A. Forastiere

Pathologic downstaging with taxane-based neoadjuvant chemotherapy correlates with increased survival in patients with locally advanced esophageal cancer

2005

Michael K. Gibson
Malcolm V. Brock
Elizabeth A. Montgomery
Joseph M. Herman
Stephen B. Baylin
Elisabeth I. Heath
Richard F. Heitmiller
Arlene A. Forastiere

4039 Background: We previously reported the effect of neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer treated with concurrent cisp...

Keywords:

Taxane
Oncology
Chemotherapy
Esophageal cancer
Internal medicine
Medicine
neoadjuvant chemoradiotherapy
in patient
locally advanced
Pathologic stage

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations